Jonghanne Park

基本信息

Career Trajectory

Bio

Study-responsible physician of an unprecedently comprehensive global Ph3 program in the CV therapeutic area - leading a number of program-level activities and a mega outcome trial.

Research Interests

Papers共 144 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

P125 Ankylosing Spondylitis Can Influence the Outcome of Inflammatory Bowel Disease

Y. K. Jun,A. H. Kim,J. Park, E. Choi,H. Yoon,H. W. Kang, H. J. Lee,J. P. Im, J. S. Kim, K. Seong-Joon

Journal of Crohn's and colitis（2022）

Cited0Views0Bibtex

Artificial Intelligence–Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non–Small-Cell Lung Cancer

Jonghanne Park,Hyung-Gyo Cho,Jewel Park,Grace Lee,Hye Sung Kim,Kyunghyun Paeng,Sanghoon Song,Gahee Park,Chan-Young Ock,Young Kwang Chae

AMERICAN JOURNAL OF PATHOLOGY（2022）

Cited6Views0WOSBibtex

Prediction of Atrial Fibrillation in Patients with Embolic Stroke with Undetermined Source Using Electrocardiogram Deep Learning Algorithm and Clinical Risk Factors

J. H. Lee,J. Kwon,M. S. Lee,Y. Cho, I. Y. Oh,J. Park,K. H. Jeon

European heart journal（2022）

Cited0Views0Bibtex

Artificial Intelligence-based Radiomics in the Era of Immuno-Oncology

Cyra Y. Kang,Samantha E. Duarte,Hye Sung Kim,Eugene Kim,Jonghanne Park,Alice Daeun Lee,Yeseul Kim,Leeseul Kim,Sukjoo Cho, Yoojin Oh,Gahyun Gim,Inae Park,Dongyup Lee,Mohamed Abazeed,Yury S. Velichko,Young Kwang Chae

ONCOLOGIST（2022）

Cited10Views0WOSBibtex

Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitor as first-line therapy

Dongyup Lee,Jonghanne Park,Horyun Choi,Gahyun Gim,Sukjoo Cho,Leeseul Kim,Youjin Oh,Cyra Y Kang, Yeseul Kim,Dean Tan,Pedro Antonio Hermida de Viveiros,Young Kwang Chae

crossref（2021）

Cited0Views0Bibtex

Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitor as first-line therapy

D. Lee,J. Park, H. Choi, G. Gim,S. Cho,L. Kim,Y. Oh,C. Kang, Y. Kim,D. Tan,P. Viveiros,Y. Chae

medRxiv (2021)

Cited0Views0Bibtex

Association of HLA class I homozygosity with unfavorable clinical outcomes in patients with non-small cell lung cancer treated with chemo-immunotherapy or immunotherapy as first-line therapy

Dongyup Lee,Jonghanne Park,Horyun Choi,Gahyun Gim,Sukjoo Cho,Leeseul Kim,Youjin Oh,Cyra Y. Kang,Yeseul Kim,Dean Tan,Pedro Antonio Hermida de Viveiros,Young Kwang Chae

HELIYON（2021）

Cited5Views0WOSBibtex

Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis

Sukjoo Cho,Jonghanne Park,Misuk Lee,Dongyup Lee,Horyun Choi,Gahyun Gim,Leeseul Kim,Cyra Y Kang,Youjin Oh,Pedro Viveiros,Elena Vagia,Michael S Oh,Geum Joon Cho,Ankit Bharat,Young Kwang Chae

Translational lung cancer researchno. 4 (2021): 1700-1710

Cited3Views0WOSBibtex

Association of HLA Class 1 Homozygosity with Unfavorable Clinical Outcomes in Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with PD-1 Inhibitor As First-Line Therapy

Young Kwang Chae,Dongyup Lee,Jonghanne Park,Horyun Choi,Gahyun Gim,Sukjoo Cho,Leeseul Kim,Youjin Oh,Cyra Y. Kang,Pedro Antonio Hermida de Viveiros

JOURNAL OF CLINICAL ONCOLOGY（2020）

Cited0Views0Bibtex

Abstract 5076: Comprehensive deep learning analysis of H&E tissue phenomics reveals distinct immune landscape and transcriptomic enrichment profile among immune inflamed, excluded and desert subtypes in non-small cell lung cancer

Jonghanne Park,Chan-Young Ock,Kyunghyun Paeng,Sehhoon Park,Horyun Choi,Dongyup Lee,Gahyun Gim,Sukjoo Cho,Yoon La Choi,Se-Hoon Lee,Young Kwang Chae

Tumor Biology（2020）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Director

Papers共 144 篇Author StatisticsCo-AuthorSimilar Experts